Beta Drugs Fair Value
Fair Value Analysis Export
Valuation Summary
P/B Based Valuation
Asset-Based Valuation
Discounted Cash Flow (DCF)
Analysis Overview
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Related Pages for Beta Drugs
Additional stock information and data for BETA
Peer Valuation Comparison
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Acutaas Chemicals | ACUTAAS | - | 10.13 | ₹14,322 |
| Murae Organisor | MURAE | - | 0.27 | ₹57 |
| Sanofi Consumer Healthca… | SANOFICONR | 46.4 | 39.33 | ₹10,281 |
| Accretion Pharmaceuticals | ACCPL | - | 2.15 | ₹98 |
| Par Drugs & Chemical | PAR | - | 1.21 | ₹132 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.